338 related articles for article (PubMed ID: 22951826)
1. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells.
Li W; Moltedo B; Moran TM
J Virol; 2012 Nov; 86(22):12304-12. PubMed ID: 22951826
[TBL] [Abstract][Full Text] [Related]
2. Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia.
Cao J; Wang D; Xu F; Gong Y; Wang H; Song Z; Li D; Zhang H; Li D; Zhang L; Xia Y; Xu H; Lai X; Lin S; Zhang X; Ren G; Dai Y; Yin Y
EMBO Mol Med; 2014 Jan; 6(1):120-40. PubMed ID: 24408967
[TBL] [Abstract][Full Text] [Related]
3. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.
Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A
mBio; 2016 May; 7(3):. PubMed ID: 27143388
[TBL] [Abstract][Full Text] [Related]
4. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
[TBL] [Abstract][Full Text] [Related]
5. Protective role of γδ T cells in cigarette smoke and influenza infection.
Hong MJ; Gu BH; Madison MC; Landers C; Tung HY; Kim M; Yuan X; You R; Machado AA; Gilbert BE; Soroosh P; Elloso M; Song L; Chen M; Corry DB; Diehl G; Kheradmand F
Mucosal Immunol; 2018 May; 11(3):894-908. PubMed ID: 29091081
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection.
Nakasone C; Yamamoto N; Nakamatsu M; Kinjo T; Miyagi K; Uezu K; Nakamura K; Higa F; Ishikawa H; O'brien RL; Ikuta K; Kaku M; Fujita J; Kawakami K
Microbes Infect; 2007 Mar; 9(3):251-8. PubMed ID: 17306586
[TBL] [Abstract][Full Text] [Related]
7. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.
Shahangian A; Chow EK; Tian X; Kang JR; Ghaffari A; Liu SY; Belperio JA; Cheng G; Deng JC
J Clin Invest; 2009 Jul; 119(7):1910-20. PubMed ID: 19487810
[TBL] [Abstract][Full Text] [Related]
8. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
[TBL] [Abstract][Full Text] [Related]
10. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection.
McNamee LA; Harmsen AG
Infect Immun; 2006 Dec; 74(12):6707-21. PubMed ID: 16982840
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
12. Host-derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infection.
Wang X; Lin X; Zheng Z; Lu B; Wang J; Tan AH; Zhao M; Loh JT; Ng SW; Chen Q; Xiao F; Huang E; Ko KH; Huang Z; Li J; Kok KH; Lu G; Liu X; Lam KP; Liu W; Zhang Y; Yuen KY; Mak TW; Lu L
Nat Commun; 2021 Mar; 12(1):1914. PubMed ID: 33772013
[TBL] [Abstract][Full Text] [Related]
13. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
[TBL] [Abstract][Full Text] [Related]
14. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
mBio; 2019 May; 10(3):. PubMed ID: 31064834
[TBL] [Abstract][Full Text] [Related]
15. Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive
Verma AK; Bansal S; Bauer C; Muralidharan A; Sun K
J Immunol; 2020 Sep; 205(6):1601-1607. PubMed ID: 32796026
[TBL] [Abstract][Full Text] [Related]
16. Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.
Blok DC; van der Sluijs KF; Florquin S; de Boer OJ; van 't Veer C; de Vos AF; van der Poll T
PLoS One; 2013; 8(3):e58191. PubMed ID: 23483993
[TBL] [Abstract][Full Text] [Related]
17. IL-21R signaling suppresses IL-17+ gamma delta T cell responses and production of IL-17 related cytokines in the lung at steady state and after Influenza A virus infection.
Moser EK; Sun J; Kim TS; Braciale TJ
PLoS One; 2015; 10(4):e0120169. PubMed ID: 25849970
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia.
Peng Y; Wang X; Wang H; Xu W; Wu K; Go X; Yin Y; Zhang X
Clin Exp Immunol; 2021 Sep; 205(3):379-390. PubMed ID: 34061992
[TBL] [Abstract][Full Text] [Related]
19. Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity.
Guo XJ; Dash P; Crawford JC; Allen EK; Zamora AE; Boyd DF; Duan S; Bajracharya R; Awad WA; Apiwattanakul N; Vogel P; Kanneganti TD; Thomas PG
Immunity; 2018 Sep; 49(3):531-544.e6. PubMed ID: 30170813
[TBL] [Abstract][Full Text] [Related]
20. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.
Barthelemy A; Ivanov S; Fontaine J; Soulard D; Bouabe H; Paget C; Faveeuw C; Trottein F
Mucosal Immunol; 2017 Mar; 10(2):460-469. PubMed ID: 27220813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
